血管紧张素转换酶抑制剂辅助激素治疗原发性肾病综合征的效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of angiotensin converting inhibitor assist hormone in the treatment of primary nephrotic syndrome.Methods 60 primary nephrotic syndrome patients treated in our hospital from November 2013 to November 2015 were selected as study objects.All patients were divided into the control group and the experimental group according to the random number table method,and each group was 30 cases.The control group was treated with hormone and the experimental group was treated with angiotensin converting inhibitor assist hormone.The treatment effect of the two groups was compared.Results The total effective rate in the experimental group was 83.33%,which was higher than that in control group(50.00%),with significant difference(P＜0.05).The level of 24 h urinary protein,urea nitrogen,serum creatinine after treatment in the two groups was lower than that before treatment,the level of plasma albumin after treatment in the two groups was higher than that before treatment,with significant difference(P＜0.05).The level of 24 h urinary protein,urea nitrogen,serum creatinine after treatment in the experimental group was lower than that in the control group after treatment,the level of plasma albumin after treatment in the experimental group was higher than that in the control group after treatment,with significant difference(P＜0.05).The total incidence rate of adverse reaction in the experimental group was 3.33%,which was lower than that in the control group(16.67%),with significant difference(P＜0.05).Conclusion The effect of angiotensin converting enzyme inhibitors in the treatment of primary nephrotic syndrome is better.

Key words： Angiotensin converting inhibitor Hormone Treatment Primary nephrotic syndrome

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Feng-xia
	XU Rui-quan
	TANG Xian-hu
	LI Xiao-sheng
	WANG Run-xiu

Cite this article:

ZHANG Feng-xia,XU Rui-quan,TANG Xian-hu, et al. Effect of angiotensin converting inhibitor assist hormone in the treatment of primary nephrotic syndrome[J]. 中国当代医药, 2017, 24(7): 82-84.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I7/82

[1]	杜春花.血管紧张素转换酶抑制剂辅助激素治疗原发性肾病综合征患者的临床效果观察[J].中国民康医学，2015，27（15）：51-52.
[2]	庄乙君，胡学芹，林叶，等.老年原发性肾病综合征患者上呼吸道感染的临床分析[J].中华医院感染学杂志，2014，24（15）：3731-3733.
[3]	张芳敏，韩子明，赵德安，等.Toll样受体4和Toll样受体7在儿童原发性肾病综合征患儿肾组织中的表达及意义[J].临床儿科杂志，2014，32（6）：512-516.
[4]	刘姝.黄芪注射液治疗原发性肾病综合征的临床疗效观察[J].中医药学报，2014，42（1）：134-136.
[5]	肖慧捷，李倩，王芳，等.儿童原发性肾病综合征合并高尿酸血症临床分析[J].中华儿科杂志，2014，52（11）：859-862.
[6]	张碧丽，刘涛，林书祥，等.儿童原发性肾病综合征激素耐药危险因素分析及预测模型建立[J].中华肾脏病杂志，2015，31（6）：414-418.
[7]	管娜，丁洁，杨霁云，等.单中心20年原发性肾病综合征不同激素效应患儿临床特点及预后分析[J].中华实用儿科临床杂志，2014，29（17）：1291-1295.
[8]	黄静蓉.老年原发性肾病综合征患者临床病理特征及血清中炎性因子的表达[J].中华老年医学杂志，2015，34（11）：1207-1209.
[9]	张晓波，李鞠，乔善磊，等.应用代谢组学方法构建原发性肾病综合征诊断模型[J].中华肾脏病杂志，2016，32（5）：334-338.
[10]	戴如凤，方晓燕，李国民，等.原发性肾病综合征患儿血清及尿液中血管生成素样蛋白3和4的临床意义[J].中华肾脏病杂志，2015，31（10）：721-728.
[11]	于续芳，黄占东.激素联合环磷酰胺及福辛普利治疗重型IgA肾病临床分析[J].山西医药杂志，2014，43（22）：2652-2654.
[12]	操轩.尿IL-18对原发性肾病综合征并发急性肾损伤的预测价值[J].中华全科医学，2015，13（1）：60-61，77.
[13]	雷文娟，张铿，潘庆军，等.原发性肾病综合征患者急性肾损伤标志物的检测及其意义[J].中国中西医结合肾病杂志，2016，17（6）：499-501.
[14]	王亚莉，王建生.糖皮质激素联合复方α-酮酸治疗原发性肾病综合征的临床观察[J].实用医学杂志，2015，31（19）：3185-3188.
[15]	陈晓萌，苏建荣.原发性肾病综合征患者血脂代谢及免疫调节的临床研究[J].国际检验医学杂志，2014，35（9）：1124-1125，1128.
[16]	杨正国，徐磊，郑金亮，等.免疫抑制剂治疗原发性肾病综合征伴慢性肾功能不全的疗效观察[J].中华老年多器官疾病杂志，2014，13（2）：119-122.